Fresenius Medical Care AG (FMS,FME.DE), a provider of dialysis products and services, on Wednesday announced that it has appointed Charles Hugh-Jones as Global Chief Medical Officer on January 1, 2026.
Charles Hugh-Jones will be a member of the Management Board and will take over from Franklin Maddux after announcing the intention to retire.
Hugh-Jones most recently served as CEO of Volastra Therapeutics and had been Chief Medical Officer at Allergan.
Charles Hugh-Jones said that the company is about to set a new standard of kidney care in the U.S. with the rollout of the 5008X CAREsystem.
Fresenius Medical is 0.61% higher at EUR 39.50 on the XETRA.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.